牛叉诊股

[{"date":"2026.08.21","stock":"-6.03","trade":"-3.66","ind":"0.87"},{"date":"2026.08.20","stock":"3.88","trade":"3.82","ind":"0.59"},{"date":"2026.08.19","stock":"-2.90","trade":"-2.08","ind":"-5.01"},{"date":"2026.08.18","stock":"-2.27","trade":"-0.60","ind":"-0.56"},{"date":"2026.08.17","stock":"0.57","trade":"0.71","ind":"2.44"},{"date":"2026.08.14","stock":"-3.04","trade":"-0.46","ind":"0.45"},{"date":"2026.08.13","stock":"0.00","trade":"1.38","ind":"-0.87"},{"date":"2026.08.12","stock":"2.26","trade":"0.65","ind":"1.09"},{"date":"2026.08.11","stock":"1.14","trade":"0.17","ind":"-0.40"},{"date":"2026.08.10","stock":"2.04","trade":"1.23","ind":"0.04"},{"date":"2026.08.07","stock":"4.26","trade":"4.40","ind":"1.42"},{"date":"2026.08.06","stock":"-1.50","trade":"0.12","ind":"-0.24"},{"date":"2026.08.05","stock":"-2.05","trade":"0.50","ind":"1.86"},{"date":"2026.08.04","stock":"1.49","trade":"2.05","ind":"3.25"},{"date":"2026.08.03","stock":"1.82","trade":"0.60","ind":"-0.96"},{"date":"2026.07.31","stock":"0.92","trade":"1.69","ind":"2.21"},{"date":"2026.07.30","stock":"-1.51","trade":"-1.97","ind":"-2.73"},{"date":"2026.07.29","stock":"0.91","trade":"0.51","ind":"1.10"},{"date":"2026.07.28","stock":"0.00","trade":"-1.30","ind":"-4.52"},{"date":"2026.07.27","stock":"3.13","trade":"3.35","ind":"2.72"},{"date":"2026.07.24","stock":"-3.33","trade":"-4.36","ind":"-2.47"}]

德展健康,深证成指,化学制药指数

压力支撑

该股压力位为3.31元，支撑位为3.22元。

[{"text":"\u538b\u529b\u4f4d","value":"3.31","date":1787241600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"3.22","date":1787241600,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：1.6资金面打败了2%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：08月21日 20:30

机构今日流向(万元)	-3797.10	机构5日流向(万元)	-8069.12
机构10日流向(万元)	-14999.39	机构20日流向(万元)	-14607.52

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少20833.19万股，其中基金净减仓6家，主力净减仓12家，请投资者中长期谨慎为宜。

截止2025-12-31，共32家主力机构（基金28家，一般法人4家），持仓量总计74969.76万股，占流通A股35.76%
其中，基金持仓与2025-06-30相比：
增仓：6家，增持 363.73万股
减仓：12家，减持 31.60万股
新出现在主力名单中：10家，持有75.78万股
从主力名单中消失：22家，原持有21204.45万股

消息面诊股

诊断结果：5消息面打败了15%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	重大事项	公司股东股份冻结	2026-08-08
重大利空	业绩预告	预计续亏	2026-07-15
一般消息	资产重组	公司股权转让	2026-06-30
一般消息	重大事项	公司股东股份解押	2026-06-27
一般消息	股东大会	临时股东大会	2026-05-28
一般消息	分红转增	不分配不转增	2026-04-25
一般消息	高管变动	因工作调整原因	2026-03-05
重大利空	业绩预告	预计增亏	2026-01-31
一般消息	高管变动	个人原因	2025-12-13
一般消息	资产重组	公司股权转让	2025-08-26
一般消息	分红转增	不分配不转增	2025-08-23

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	2条	2条	0条

行业面诊股

诊断结果：6.2行业面打败了72%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构对该行业关注较少，无任何评级。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑赢大盘。

[{"date":"2026.08.21","price":"0.87","value":"-3.66"},{"date":"2026.08.20","price":"0.59","value":"3.82"},{"date":"2026.08.19","price":"-5.01","value":"-2.08"},{"date":"2026.08.18","price":"-0.56","value":"-0.60"},{"date":"2026.08.17","price":"2.44","value":"0.71"},{"date":"2026.08.14","price":"0.45","value":"-0.46"},{"date":"2026.08.13","price":"-0.87","value":"1.38"},{"date":"2026.08.12","price":"1.09","value":"0.65"},{"date":"2026.08.11","price":"-0.40","value":"0.17"},{"date":"2026.08.10","price":"0.04","value":"1.23"},{"date":"2026.08.07","price":"1.42","value":"4.40"},{"date":"2026.08.06","price":"-0.24","value":"0.12"},{"date":"2026.08.05","price":"1.86","value":"0.50"},{"date":"2026.08.04","price":"3.25","value":"2.05"},{"date":"2026.08.03","price":"-0.96","value":"0.60"},{"date":"2026.07.31","price":"2.21","value":"1.69"},{"date":"2026.07.30","price":"-2.73","value":"-1.97"},{"date":"2026.07.29","price":"1.10","value":"0.51"},{"date":"2026.07.28","price":"-4.52","value":"-1.30"},{"date":"2026.07.27","price":"2.72","value":"3.35"},{"date":"2026.07.24","price":"-2.47","value":"-4.36"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	神奇制药	91.49%	40.41%	6.4分
2	誉衡药业	57.61%	-3.97%	5.9分
3	哈药股份	51.30%	-8.31%	6.5分
4	键凯科技	47.47%	30.58%	5.7分
5	东亚药业	44.76%	11.63%	4.9分
6	永安药业	42.65%	25.49%	6.0分
7	北陆药业	41.27%	19.59%	6.4分
8	西点药业	41.22%	1.72%	5.4分
9	双鹭药业	33.84%	17.22%	5.7分
10	石药创新	32.79%	20.19%	6.3分
11	科源制药	29.59%	0.94%	5.5分
12	海森药业	28.54%	12.55%	5.3分
13	花园生物	28.24%	-3.08%	4.9分
14	中关村	25.68%	18.37%	5.7分
15	悦康药业	25.31%	4.76%	5.6分
16	冀衡医药	24.16%	-4.92%	4.4分
17	亚太药业	23.58%	-6.14%	5.2分
18	广济药业	23.40%	1.11%	5.6分
19	纳微科技	23.26%	-1.03%	6.2分
20	汉商集团	22.82%	0.83%	6.4分
21	中哲精化	22.79%	1.30%	6.1分
22	复旦张江	22.21%	0.82%	5.8分
23	仟源医药	22.15%	-1.11%	6.0分
24	亨迪药业	22.14%	2.38%	5.5分
25	凯因科技	20.96%	-1.73%	6.0分
26	富士莱	20.90%	-0.15%	5.4分
27	哈三联	20.79%	-1.08%	5.2分
28	盟科药业	20.09%	-1.45%	6.3分
29	宣泰医药	19.46%	-9.46%	6.2分
30	金石亚药	19.35%	-7.36%	5.9分
31	汇宇制药	18.49%	-4.41%	5.7分
32	赛托生物	17.72%	0.08%	5.4分
33	莎普爱思	17.72%	0.36%	6.1分
34	海欣股份	17.58%	0.69%	5.1分
35	圣诺生物	16.91%	-4.59%	5.0分
36	丰原药业	16.73%	2.19%	5.8分
37	ST复华	16.67%	-1.46%	5.1分
38	溢多利	16.48%	0.80%	5.8分
39	立方制药	16.35%	-2.68%	5.4分
40	翰宇药业	16.14%	-10.67%	5.0分
41	-	15.14%	0.69%	分
42	向日葵	14.94%	-3.85%	3.9分
43	威尔药业	14.91%	-0.71%	6.0分
44	ST天圣	14.22%	-0.93%	5.3分
45	-	14.13%	2.44%	分
46	宏源药业	14.11%	-0.75%	5.1分
47	九典制药	13.99%	-8.32%	4.9分
48	康芝药业	13.94%	-3.07%	4.8分
49	津药药业	13.84%	-6.29%	5.4分
50	吉贝尔	13.77%	-1.94%	6.6分
51	浙江医药	13.76%	-0.75%	5.8分
52	本立科技	13.69%	-0.57%	5.6分
53	北大医药	13.28%	-4.09%	5.6分
54	海正药业	13.15%	-7.76%	5.7分
55	拓新药业	13.14%	-4.72%	4.4分
56	金城医药	12.78%	-4.38%	5.3分
57	民生健康	12.49%	-1.45%	5.6分
58	天宇股份	12.23%	-1.52%	4.8分
59	新天地	12.18%	-3.90%	4.7分
60	海普瑞	12.10%	-1.32%	5.3分
61	尔康制药	11.81%	-2.72%	5.0分
62	-	11.60%	-6.91%	分
63	昂利康	11.59%	-1.68%	4.4分
64	润都股份	11.46%	-2.84%	5.4分
65	奥翔药业	11.42%	-3.23%	5.2分
66	卫信康	11.34%	-0.21%	6.1分
67	东北制药	11.33%	-0.40%	5.7分
68	司太立	10.75%	-1.56%	4.4分
69	金陵药业	10.48%	-2.21%	5.8分
70	山河药辅	10.47%	-1.39%	5.2分
71	华仁药业	10.42%	-2.39%	5.7分
72	共同药业	10.30%	-4.66%	5.1分
73	灵康药业	10.26%	-12.88%	5.4分
74	-	10.21%	-3.77%	分
75	-	10.12%	1.92%	分
76	赛分科技	10.07%	-7.04%	6.1分
77	莱美药业	10.02%	-0.38%	5.2分
78	易明医药	9.75%	-1.87%	5.4分
79	石药景峰	9.67%	-3.74%	4.9分
80	福安药业	9.47%	-1.75%	5.7分
81	小方制药	9.12%	-2.25%	5.1分
82	首药控股	8.99%	0.56%	6.1分
83	美诺华	8.94%	-5.63%	5.2分
84	ST惠程	8.78%	-1.79%	6.1分
85	一品红	8.57%	-5.09%	4.9分
86	同和药业	8.26%	-1.84%	5.4分
87	-	8.17%	-6.33%	分
88	联环药业	7.91%	-5.56%	5.2分
89	广生堂	7.87%	-6.37%	4.2分
90	川宁生物	7.77%	1.46%	5.3分
91	上海谊众	7.73%	-2.82%	5.0分
92	华邦健康	7.14%	-1.75%	5.6分
93	ST人福	7.06%	-0.56%	5.3分
94	多瑞医药	6.93%	-2.26%	4.3分
95	-	6.80%	-2.18%	分
96	诚意药业	6.78%	-0.54%	5.1分
97	百济神州	6.73%	0.54%	5.2分
98	-	6.62%	-4.52%	分
99	海创药业	6.54%	-4.55%	5.0分
100	奥锐特	6.46%	-4.22%	4.8分
101	新华制药	6.43%	-5.04%	5.0分
102	罗欣药业	6.16%	-5.48%	4.5分
103	迪哲医药	6.12%	-3.14%	6.3分
104	复星医药	5.75%	-2.68%	5.4分
105	健友股份	5.43%	-1.49%	5.3分
106	博瑞医药	5.34%	-9.10%	4.2分
107	通化金马	5.32%	-4.35%	4.6分
108	普洛药业	5.28%	-8.12%	5.0分
109	东诚药业	5.25%	-0.99%	5.4分
110	华北制药	5.14%	-2.58%	5.3分
111	海辰药业	5.08%	-6.00%	4.5分
112	恩华药业	5.07%	-0.05%	5.7分
113	力生制药	4.64%	-3.22%	4.6分
114	海翔药业	4.17%	-2.96%	4.8分
115	千红制药	3.86%	-6.53%	4.9分
116	华海药业	3.81%	-5.19%	5.3分
117	ST诺泰	3.80%	-3.22%	4.7分
118	亿帆医药	3.37%	-4.52%	5.0分
119	鲁抗医药	3.24%	-3.68%	4.7分
120	仙琚制药	2.93%	-0.59%	5.1分
121	泰恩康	2.86%	-7.85%	4.8分
122	兴齐眼药	2.82%	-3.99%	4.9分
123	奥赛康	2.79%	-6.04%	4.8分
124	德展健康	2.51%	-6.84%	3.9分
125	辰欣药业	1.88%	-6.87%	4.3分
126	福元医药	1.77%	-8.41%	4.8分
127	富祥股份	1.76%	-5.87%	4.5分
128	信立泰	1.52%	-6.36%	5.0分
129	前沿生物	0.70%	-8.97%	4.9分
130	海思科	0.65%	-4.08%	5.5分
131	海南海药	0.41%	-11.19%	3.8分
132	国邦医药	0.32%	0.32%	4.9分
133	舒泰神	-0.05%	-11.39%	4.4分
134	国药现代	-0.12%	-3.09%	4.9分
135	微芯生物	-0.89%	-9.40%	4.9分
136	华东医药	-1.68%	-5.45%	5.1分
137	健康元	-1.69%	-3.04%	5.1分
138	京新药业	-2.08%	-6.19%	4.9分
139	艾力斯	-2.30%	-3.24%	6.2分
140	丽珠集团	-2.34%	-3.34%	5.2分
141	华纳药厂	-2.44%	-1.18%	5.3分
142	常山药业	-2.85%	-10.01%	4.5分
143	ST南新	-2.99%	-6.20%	4.0分
144	亚虹医药	-3.02%	-6.01%	4.9分
145	天新药业	-3.50%	-1.76%	5.1分
146	华润双鹤	-3.57%	-2.06%	4.8分
147	科伦药业	-3.82%	-0.53%	5.5分
148	华特达因	-4.16%	-8.07%	3.9分
149	ST能特	-4.74%	-0.90%	5.5分
150	泽璟制药	-5.33%	6.90%	6.4分
151	新和成	-6.49%	-0.86%	4.5分
152	苑东生物	-6.89%	-8.29%	5.0分
153	百利天恒	-9.10%	-6.39%	5.2分
154	恒瑞医药	-10.68%	-9.27%	5.5分
155	贝达药业	-12.24%	-25.49%	4.8分
156	必贝特	-13.40%	-5.18%	6.1分
157	益方生物	-16.00%	-5.17%	5.4分
158	-	-	-0.46%	分

<上一页 1 2 3 4 5...27 下一页>

行业评级

最近120个交易日，机构对该行业关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：4.2基本面打败了2%的股票连续3年业绩增长30%的公司

该公司运营状况不佳，暂时未获得多数机构的显著认同，长期投资价值一般。

个股深一度

潜在高分红能力：弱（32.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 123/214 ， 88/214。

[{"date":"2026-03-31","value":"-0.75","vol":"0.45"},{"date":"2025-12-31","value":"-7.05","vol":"-1.85"},{"date":"2025-09-30","value":"-1.20","vol":"1.60"},{"date":"2025-06-30","value":"-0.84","vol":"1.26"},{"date":"2025-03-31","value":"-0.43","vol":"-0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	-0.75	-7.05	-1.20	-0.84	-0.43
行业(%)	0.45	-1.85	1.60	1.26	-0.13

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"43.70","vol":"50.98"},{"date":"2025-12-31","value":"56.15","vol":"49.96"},{"date":"2025-09-30","value":"55.57","vol":"49.79"},{"date":"2025-06-30","value":"54.75","vol":"49.69"},{"date":"2025-03-31","value":"59.82","vol":"49.05"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	43.70	56.15	55.57	54.75	59.82
行业(%)	50.98	49.96	49.79	49.69	49.05

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 80/214 ， 131/214。

[{"date":"2026-03-31","value":"-0.73","vol":"24.44"},{"date":"2025-12-31","value":"-14.94","vol":"38.58"},{"date":"2025-09-30","value":"-21.71","vol":"142.64"},{"date":"2025-06-30","value":"-33.01","vol":"79.18"},{"date":"2025-03-31","value":"-11.82","vol":"0.16"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	-0.73	-14.94	-21.71	-33.01	-11.82
行业(%)	24.44	38.58	142.64	79.18	0.16

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"-55.66","vol":"52.58"},{"date":"2025-12-31","value":"-1592.15","vol":"-24.51"},{"date":"2025-09-30","value":"-854.37","vol":"3.72"},{"date":"2025-06-30","value":"-522.81","vol":"66.32"},{"date":"2025-03-31","value":"-31.60","vol":"-9.37"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	-55.66	-1592.15	-854.37	-522.81	-31.60
行业(%)	52.58	-24.51	3.72	66.32	-9.37

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 147/214 ， 108/214。

[{"date":"2026-03-31","value":"0.02","vol":"0.10"},{"date":"2025-12-31","value":"0.08","vol":"0.41"},{"date":"2025-09-30","value":"0.05","vol":"0.31"},{"date":"2025-06-30","value":"0.03","vol":"0.21"},{"date":"2025-03-31","value":"0.02","vol":"0.10"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.02	0.08	0.05	0.03	0.02
行业(次)	0.10	0.41	0.31	0.21	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.36","vol":"0.64"},{"date":"2025-12-31","value":"1.01","vol":"2.56"},{"date":"2025-09-30","value":"0.62","vol":"1.94"},{"date":"2025-06-30","value":"0.37","vol":"1.30"},{"date":"2025-03-31","value":"0.18","vol":"0.66"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.36	1.01	0.62	0.37	0.18
行业(次)	0.64	2.56	1.94	1.30	0.66

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"18.15","vol":"-2.75"},{"date":"2025-12-31","value":"-18.18","vol":"16.48"},{"date":"2025-09-30","value":"-1.25","vol":"4.59"},{"date":"2025-06-30","value":"12.66","vol":"2.93"},{"date":"2025-03-31","value":"20.21","vol":"-26.34"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	18.15	-18.18	-1.25	12.66	20.21
行业	-2.75	16.48	4.59	2.93	-26.34

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"2.15","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.02","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	2.15	-	2.02	-
行业	0.00	1.60	0.00	1.72	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 146/214 ， 146/214。

[{"date":"2026-03-31","value":"16.69","vol":"3.58"},{"date":"2025-12-31","value":"16.48","vol":"3.33"},{"date":"2025-09-30","value":"28.79","vol":"3.50"},{"date":"2025-06-30","value":"34.79","vol":"3.68"},{"date":"2025-03-31","value":"25.57","vol":"3.58"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	16.69	16.48	28.79	34.79	25.57
行业	3.58	3.33	3.50	3.68	3.58

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"15.27","vol":"2.94"},{"date":"2025-12-31","value":"15.26","vol":"2.71"},{"date":"2025-09-30","value":"26.65","vol":"2.75"},{"date":"2025-06-30","value":"32.19","vol":"2.90"},{"date":"2025-03-31","value":"23.84","vol":"2.81"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	15.27	15.26	26.65	32.19	23.84
行业	2.94	2.71	2.75	2.90	2.81

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 146/214 ， 147/214。

[{"date":"2026-03-31","value":"5.66","vol":"33.40"},{"date":"2025-12-31","value":"6.15","vol":"34.57"},{"date":"2025-09-30","value":"5.18","vol":"34.00"},{"date":"2025-06-30","value":"4.97","vol":"34.11"},{"date":"2025-03-31","value":"4.11","vol":"34.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	5.66	6.15	5.18	4.97	4.11
行业(%)	33.40	34.57	34.00	34.11	34.06

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.06","vol":"9.83"},{"date":"2025-12-31","value":"0.06","vol":"1.77"},{"date":"2025-09-30","value":"0.05","vol":"1.19"},{"date":"2025-06-30","value":"0.05","vol":"0.88"},{"date":"2025-03-31","value":"0.04","vol":"1.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.06	0.06	0.05	0.05	0.04
行业(%)	9.83	1.77	1.19	0.88	1.44

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"-0.47","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.83","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.20","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-3.45","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[德展健康]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]